Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, absolute, Affymax, Agha, AHGD, antihypertensive, appl, Arqule, Astex, Austria, Aveo, Basel, BCF, Belgium, BioReliance, blockbuster, Boehringer, Bone, Bristol, British, Buchholz, budgetary, CDRSA, Cleveland, COBRA, contributor, Cozaar, Danish, Darmstadt, David, Delaware, denied, deployment, deviation, disadvantage, disciplined, dismissed, disputed, docketing, Dodd, empower, envelope, Ergomed, Erlangen, Exelon, exploratory, FCPA, fell, Fosamax, Fulbright, Galena, Gallagher, Georgia, GlyPharma, Harvard, Helix, hinder, host, hundred, inflationary, infrastructure, Ingelheim, intramuscular, Isoray, JP, Jude, Karger, Leader, MACRILEN, Maxalt, Maxigen, Mead, medium, merge, Merrimack, Millipore, mixture, MSA, Navigant, Neurosurgery, NGC, Obama, offeror, outsource, overhaul, oversaw, pat, Patch, PDUFA, peer, Peregrine, persuade, Pharmathene, physical, Popovic, prejudice, Prolia, PROREIT, PTA, Puerto, Pyridopyrazine, ramping, realign, Reda, Repligen, reposition, representation, resignation, Rico, Sachse, Salzburg, scientist, serial, Singulair, southeastern, Stefan, superseded, Targacept, Tekturna, therefrom, timeline, transformation, TSA, UCB, underwritten, unilaterally, Unimed, unnecessarily, USC, User, Verastem, Vical, Vioxx, visualized, Vytorin, warehousing, whichever, wholly, won, ZoptEC
Removed:
Acadia, acetate, acid, Andrew, AON, Arcoda, Array, assisted, avoided, banking, Beecham, Biochemistry, BioMedica, biomedical, BioSant, Blaikie, blocked, bortezomib, BS, capecitabine, carcinoma, castrating, cautioned, Cephalon, cetrorelix, chronic, Chugai, CMC, companion, comparatively, Conversely, device, dexamethasone, diagnosed, distribute, East, Educational, egg, ElexoPharm, endocrine, enrolment, Enzon, equimolar, estimable, estimating, fifty, foreseen, founding, ganirelix, Genomic, GIG, gradually, GSK, Hambrecht, Heenan, hormonal, hyperstimulation, importance, inherited, initiate, injectable, injection, internally, Internet, Isotechnika, Keryx, launched, Laureate, Leiden, LH, lieu, Ligand, London, LP, Lynch, lyophilizate, lyophilization, margin, marked, maturation, Merrill, Mount, naturally, Neurocrine, neurotoxicology, Nobel, Nps, obstructive, omitted, onset, Onyx, optionee, organic, outlook, ovulation, Oxford, pancreatic, pharmaceutically, pharmacologic, Plough, Polytechnic, premature, presently, prospective, pulmonary, Quist, recoup, recovery, redesignated, regained, relapsed, releasing, remit, reproductive, retrieve, revision, Roche, Royal, San, Schally, Schering, seasoned, Seeber, sexual, short, Sinai, sleep, slightly, SmithKline, solution, South, spent, St, sterile, stimulating, strive, surge, suspended, Switzerland, syndrome, twenty, UK, undergo, undergoing, undue, update, variation, Velcade, Xeloda, Xoma, Zurich
Filing tables
Filing exhibits
AEZS similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT AUDITOR
We hereby consent to the incorporation by reference in the registration statement on Form F-3 (No. 333-194547) and F-10/A (No. 333-194080) of Aeterna Zentaris Inc. of our report dated March 20, 2014 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
![](https://capedge.com/proxy/20-F/0001113423-14-000004/signatpwc.jpg)
Québec, Quebec
March 20, 2014
1 CPA auditor, CA, public accountancy permit No. A123498